Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER × Immunoconjugates × Clear all

Status

Not yet recruiting 2 Completed 2 Withdrawn 1 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Lymphoma, B-Cell 1 Burkitt Lymphoma 1

Interventions

Radiotherapy 280 Specimen Handling 276 Magnetic Resonance Spectroscopy 276 pembrolizumab 260 Cyclophosphamide 248 Cisplatin 224 Carboplatin 208 Drug Therapy 198 Blood Specimen Collection 198 Biopsy 166 Gemcitabine 153 Bevacizumab 150 venetoclax 149 Radiosurgery 145 fludarabine 140 Nivolumab 135 Oxaliplatin 134 Capecitabine 132 Paclitaxel 128 Standard of Care 119 Surgical Procedures, Operative 113 Surveys and Questionnaires 108 Fluorouracil 107 Dexamethasone 107 Docetaxel 99 tislelizumab 93 Rituximab 92 Radiation 91 Cytarabine 90 durvalumab 81

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06796517 2025-01-28

Immunotherapy in Lymphoma

Seoul St. Mary's Hospital

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡